Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Jasper Therapeutics Inc (JSPR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Jasper Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
21.590 -1.620    -6.98%
16:00:01 - Closed. Currency in USD ( Disclaimer )
After Hours
20.930
-0.660
-3.057%
18:53:51 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 64,552
  • Bid/Ask: 19.890 / 21.910
  • Day's Range: 21.430 - 23.580
Jasper Therapeutics 21.590 -1.620 -6.98%

JSPR Recent Sentiments

 
This page contains information on users’ sentiments for the Jasper Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Mar 25, 2024 mike Rodríguez   26.965 Apr 19, 2024 @ 21.590 -19.93%
Mar 21, 2024 abdulazez alfayez   29.000 Apr 12, 2024 @ 27.720 -4.41%
Mar 15, 2024 Emile Hawawini   25.010 Apr 05, 2024 @ 29.500 +17.95%
Mar 15, 2024 Kwame Mensah   25.520 Apr 05, 2024 @ 29.500 +15.60%
Mar 11, 2024 Tsvi Elster   27.550 Mar 18, 2024 @ 24.315 -11.74%
Feb 26, 2024 Mariya Plevako   20.500 Mar 22, 2024 @ 29.230 +42.59%
Feb 23, 2024 Richard Giocondo   18.805 Mar 15, 2024 @ 25.080 +33.37%
Feb 15, 2024 Kwame Mensah   18.690 Mar 08, 2024 @ 27.550 +47.41%
Feb 06, 2024 Süleyman Kılınç   14.000 Feb 12, 2024 @ 17.020 -21.57%
Jan 18, 2024 Mariya Plevako   12.400 Feb 09, 2024 @ 17.590 +41.85%
Dec 28, 2023 umut kılıç   710.000 Jan 19, 2024 @ 11.020 -98.45%
Sep 11, 2023 Suhar Suhar   0.843 Nov 30, 2023 @ 0.590 -30.01%
Aug 07, 2023 Netanel Amsalem   1.470 Nov 30, 2023 @ 0.590 -59.86%
May 15, 2023 Сергей Ляхов   1.545 Nov 30, 2023 @ 0.590 -61.81%
Mar 22, 2023 Franco Arbulla   1.945 Apr 14, 2023 @ 1.450 -25.45%
Mar 08, 2023 Waleed ali   1.970 Mar 31, 2023 @ 1.810 -8.12%
Mar 08, 2023 Abdelmlk Mohamed   2.000 Mar 31, 2023 @ 1.810 -9.50%
Feb 07, 2023 Ibraheem Aide   1.859 Feb 13, 2023 @ 1.730 -6.94%
Feb 02, 2023 roberto ponzo   1.705 Feb 24, 2023 @ 1.760 +3.23%
Jan 17, 2023 Musa Kefkir   1.960 Feb 10, 2023 @ 1.780 -9.18%
Jan 13, 2023 Robbert Kuipers   2.620 Feb 03, 2023 @ 1.930 -26.34%
Jan 13, 2023 Robbert Kuipers   2.610 Jan 13, 2023 @ 2.610 0.00%
Jan 13, 2023 Roberto Spinelli   2.610 Feb 03, 2023 @ 1.930 +26.05%
Jan 13, 2023 Tatiana Shuginova   2.389 Feb 03, 2023 @ 1.930 -19.21%
Jan 09, 2023 Peter Meško   1.770 Feb 03, 2023 @ 1.930 +9.04%
Jan 09, 2023 Piero Santoro   1.570 Feb 03, 2023 @ 1.930 -22.93%
Jan 04, 2023 Nestor Balintec   2.050 Jan 27, 2023 @ 1.740 -15.12%
Jan 04, 2023 Zico Diciassette   2.120 Jan 09, 2023 @ 1.590 -25.00%
Jan 04, 2023 Sean Taylor   1.982 Jan 27, 2023 @ 1.740 -12.21%
Jan 04, 2023 Franco Arbulla   2.129 Jan 27, 2023 @ 1.740 -18.27%
Jan 04, 2023 Ümit Çınar   2.180 Jan 04, 2023 @ 2.051 +5.92%
Jan 03, 2023 Michele Forcillo   3.280 Jan 04, 2023 @ 2.140 +34.76%
Jan 03, 2023 Piero Santoro   3.280 Jan 04, 2023 @ 2.100 -35.98%
Jan 03, 2023 Piero Santoro   3.180 Jan 03, 2023 @ 3.280 +3.14%
Jan 03, 2023 jasr alzhrani   3.298 Jan 27, 2023 @ 1.740 -47.24%
Jan 03, 2023 AJ AJ   3.345 Jan 27, 2023 @ 1.740 -47.98%
Jan 03, 2023 Giovanni Conti   2.910 Jan 27, 2023 @ 1.740 -40.21%
Jan 03, 2023 mahmoud gamal   3.070 Jan 27, 2023 @ 1.740 -43.32%
Jan 03, 2023 Mariya Plevako   2.730 Jan 27, 2023 @ 1.740 -36.26%
Jan 03, 2023 Ümit Çınar   3.020 Jan 03, 2023 @ 2.950 +2.32%
Jan 03, 2023 Jen Gittes   3.020 Jan 27, 2023 @ 1.740 -42.38%
Jan 03, 2023 Mitch   3.410 Jan 27, 2023 @ 1.740 +48.97%
Jan 03, 2023 Luis Miguel Vena...   3.410 Jan 27, 2023 @ 1.740 -48.97%
Jan 03, 2023 Robbert Kuipers   3.210 Jan 27, 2023 @ 1.740 -45.79%
Jan 03, 2023 Robbert Kuipers   2.730 Jan 03, 2023 @ 3.340 +22.34%
Jan 03, 2023 telemaco michailidis   2.800 Jan 06, 2023 @ 1.810 -35.36%
Jan 03, 2023 Angelo Pistilli   2.560 Jan 27, 2023 @ 1.740 +32.03%
Jan 03, 2023 Piero Santoro   2.560 Jan 03, 2023 @ 3.180 -24.22%
Jan 03, 2023 Piero Santoro   2.470 Jan 03, 2023 @ 2.560 +3.64%
Jan 03, 2023 Tyler Philipation   2.470 Jan 04, 2023 @ 2.110 +14.57%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

JSPR Comments

Write your thoughts about Jasper Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sean Taylor
Sean Taylor Jan 10, 2023 8:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice jump up. glad I held between 1.65 and 1.90
Sean Taylor
Sean Taylor Jan 04, 2023 7:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
we reloading for $3.50 today guys???
Mitch
Mitch Jan 03, 2023 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Awesome trade! BJDX will make a similar move - get in before the FDA news is out!
Raul Garcia
Raul Garcia Jan 03, 2023 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
con tantas paradas no se puede, joer
Robert Kiel
Robert Kiel Jan 03, 2023 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Party
Raul Garcia
Raul Garcia Jan 03, 2023 11:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nadie en esta fiesta?
Scott Ornelas
Jatslo Oct 18, 2021 1:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JSPR (P) 0.00000000 16.41000000
Scott Ornelas
Jatslo Oct 14, 2021 11:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sold #JSPR @ 16.41000000
DW Chadz
Calgarychadz Oct 13, 2021 4:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A buy recommendation is that valuable?
Eric Grant
Eric Grant Oct 13, 2021 4:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JSPR Analyst RatingsCONSENSUSStrong BuyBased on 4 analysts offering recommendations for 'JSPR' in the last 3 months.
Batuhan Babür
Batuhan Babür Oct 13, 2021 1:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Missed it...
Giuseppe Giannachi
Giuseppe Giannachi Oct 13, 2021 1:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Same here
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email